Keywords:
Brain tumour; Challenges; Innovations; Trials
Abstract:
This review identifies challenges and barriers to successful development of drugs in neuro-oncology trials at the preclinical, clinical and translational stages that we believe has contributed to poor outcomes for patients over the last 30 years.